UBS cuts Paychex stock price target to $98 on revenue growth concerns

UBS cut Paychex’s price target to $98 from $100 while keeping a Neutral rating, citing softer-than-expected revenue growth outlook of 5%–6% for fiscal 2027 after the $4.1 billion Paycor integration. Offseting that, Paychex reported fiscal Q4 2026 adjusted EPS of $1.32 on revenue of $1.61 billion, with full-year revenue up 17% to $6.5 billion and fiscal 2027 adjusted operating margin guidance near 44%. The company also announced $2.2 billion of fiscal 2026 capital returns, including $1.6 billion in dividends and $600 million in buybacks.

Analysis

PAYX is being treated like a mature ex-growth compounder, but the market may be underestimating how much of the near-term disappointment is actually a denominator problem: the Paycor integration lifts reported growth mechanically, yet the Street wants a second leg of acceleration before paying for it. That creates a classic setup where the next 2-3 quarters matter more than the full-year guide — if cross-sell conversion from the acquired base shows even modest sequential improvement, the multiple can re-rate quickly because the stock is already pricing in low-single-digit organic durability.

The bigger second-order issue is competitive: the HUB alliance and AI-led workflow tools are less about headline revenue today and more about reducing customer churn and widening average revenue per client over 12-24 months. If Paychex can package payroll, retirement, ASO and PEO into a stickier mid-market platform, the real loser is not a single named competitor but the fragmented broker/outsourced HR channel that depends on low switching costs. That said, if the alliance only produces lead flow without materially improving close rates, the market will view it as a branding exercise and continue to compress the premium multiple.

Capital return is doing important support work here. A near-5% yield plus buybacks effectively sets a floor for the stock so long as cash conversion remains intact, but it also signals that management may prefer returning capital over aggressively reinvesting — which can cap upside if growth fails to inflect. The key risk is that margin guidance looks strong exactly when revenue expectations are most vulnerable; if growth misses again, investors will likely punish the stock despite the margin beat because the narrative has shifted from profitability to sustainability.

Key Decisions for Investors

• Long PAYX into the next 1-2 earnings prints if you believe cross-sell metrics will inflect; target a 8-12% rerating, with a stop if organic revenue remains stuck below market expectations for two consecutive quarters.
• Use a call spread in PAYX 3-6 months out to express upside from a growth re-acceleration while limiting downside if the market keeps treating the stock as a yield proxy.
• Pair trade: long PAYX / short a higher-multiple HR-tech or payroll software name if you expect the market to reward cash generation over topline growth; this works best over the next 1-2 quarters as guidance revisions come through.
• If long PAYX outright, trim on any move above the implied value of a high-40s/low-50s forward P/E unless revenue growth improves; the risk/reward becomes less attractive if the stock re-rates before evidence of accretion from Paycor appears.
• Watch HUBG as a read-through on mid-market distribution quality; if the alliance produces visible pipeline wins within 2-3 quarters, add to PAYX, but if no measurable conversion shows up, fade the story and keep exposure size modest.